FDA convened this weeks meeting to discuss seven unapproved peptides that are under review for various medical conditions, including ulcerative colitis, migraines and opioid addiction
doi: 10.3389/fphar.2025.1601712 Received 28 March 2025 Accepted 27 May 2025 Published 23 June 2025 Volume 16 - 2025 Edited by Ashish Mehta, Garvan Institute of Medical Research, Australia Reviewed by Ankul Singh S, ACS Medical College and Hospital, India Prabhash Nath Tripathi, University of Arkansas for Medical Sciences, United States Updates Copyright 2025 Aktary, Jeong, Oh, Shin, Sung, Rahman, Ramos Santiago, Choi, Song, Nurkolis, Ribeiro, Park and Kim
Key Takeaway: Consistency is the most critical factor in any supplement routine
What are the side effects of b12 injections
Wang KCW, Tosh DN, Zhang S, McMillen IC, Duffield JA, Brooks DA, Morrison JL
Research by Heffernan et al